https://scholarworks.samsunghospital.com:447/item/cd518bc6-d011-4f89-a118-be452d4fa940
Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in...
Choosing an optimal concomitant drug for combination with poly-ADP ribose polymerase (PARP) inhibitor based on patient-specific biomarker status may help...
randomizedtwoarmnoncomparativephase
https://profiles.foxchase.org/en/publications/a-multicenter-phase-ii-randomized-noncomparative-clinical-trial-o/
A multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide...
phase iiclinical trialmulticenterrandomizednoncomparative